[{"id":"780d5f17-6282-4eff-bdfa-6619fa8add2d","acronym":"","url":"https://clinicaltrials.gov/study/NCT05379634","created_at":"2022-05-18T11:56:57.222Z","updated_at":"2025-02-25T15:35:40.571Z","phase":"Phase 2","brief_title":"A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies","source_id_and_acronym":"NCT05379634","lead_sponsor":"Janssen Research \u0026 Development, LLC","biomarkers":" TRIM33 • IFIH1","pipe":"","alterations":" ","tags":["TRIM33 • IFIH1"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 36","initiation":"Initiation: 07/05/2022","start_date":" 07/05/2022","primary_txt":" Primary completion: 10/27/2025","primary_completion_date":" 10/27/2025","study_txt":" Completion: 09/14/2026","study_completion_date":" 09/14/2026","last_update_posted":"2025-02-10"},{"id":"5394f34f-7b04-4e1c-b288-70884b78f136","acronym":"","url":"https://clinicaltrials.gov/study/NCT03278925","created_at":"2023-12-06T22:15:51.203Z","updated_at":"2024-07-02T16:35:16.213Z","phase":"Phase 1","brief_title":"Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis","source_id_and_acronym":"NCT03278925","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" TRIM33","pipe":"","alterations":" ","tags":["TRIM33"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 14","initiation":"Initiation: 08/09/2018","start_date":" 08/09/2018","primary_txt":" Primary completion: 06/16/2023","primary_completion_date":" 06/16/2023","study_txt":" Completion: 12/31/2024","study_completion_date":" 12/31/2024","last_update_posted":"2024-03-06"}]